Respirtory Protocol

Explore current literature and clinical practice guidelines to complete the clinical treatment protocol template.

Complete the protocol outline templateLinks to an external site. to develop a protocol for asthma treatment. Use of the template is required. A 10% deduction will be applied if the template is not used. See the rubric.
Provide references for your protocol at the bottom of the form where indicated. References should come from the following sources:
Asthma Clinical Practice Guideline
Course Textbook (for individual medication information)
Journal Articles from within the last five years as defined by program expectationsLinks to an external site..
Follow APA grammar, spelling, word usage, and punctuation rules consistent with formal, scholarly writing.
No more than one short direct quote (15 words or less) may be used in this assignment.
First person should not be used within this assignment.
At least three scholarly references must be used for this assignment.
Abide by Chamberlain University's academic integrity policy.
Include the following sections (detailed criteria listed below and in the grading rubric).

Pharmacological Treatment

Correctly complete all blanks for the preferred and alternative medication for each step of therapy noted in the CPG.
List medications in order according to the CPG.
List generic medication names for each category.
Provide an in-text citation under the completed table.
Treatment Differences in Adults and Children

Correctly list the first line of initial pharmacologic treatment in step one; track one for asthmatic adults. (7a on the form)
Correctly list the first line of initial pharmacologic treatment in step one, track one for asthmatic children ages 6-11. (7b on the form)
Correctly list drug dose, route, frequency, instructions, precautions, drug cost, and education for adult and pediatric clients.
Provide in-text citations under the information for adults and pediatric clients.
Treatment Monitoring

Full Answer Section

        Treatment Differences in Adults and Children: Adults:
  • Step 1: Short-acting beta-agonist (SABA) as needed for symptoms.
  • Dose: As prescribed by a healthcare provider.
  • Route: Inhalation.
  • Frequency: As needed for symptoms.
  • Instructions: Use as directed.
  • Precautions: Monitor for side effects (e.g., tachycardia, tremors).
  • Drug cost: Varies based on insurance coverage and medication choice.
  • Education: Educate patients about proper inhaler technique, triggers, and the importance of adherence to treatment.
Children:
  • Step 1: Short-acting beta-agonist (SABA) as needed for symptoms.
  • Dose: As prescribed by a healthcare provider, based on age and weight.
  • Route: Inhalation.
  • Frequency: As needed for symptoms.
  • Instructions: Use as directed.
  • Precautions: Monitor for side effects (e.g., tachycardia, tremors).
  • Drug cost: Varies based on insurance coverage and medication choice.
  • Education: Educate parents or caregivers about proper inhaler technique, triggers, and the importance of adherence to treatment.
Reference: National Asthma Education and Prevention Program, Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2007. Treatment Monitoring:
  • Regular follow-up visits with a healthcare provider to assess symptoms, lung function, and medication effectiveness.
  • Monitoring of peak flow to track lung function.
  • Assessment of asthma exacerbations and prompt treatment.
  • Education and support for patients and their families.
Note: Please ensure that you replace the placeholder information with accurate data from your chosen sources, including specific medication dosages, routes, and frequencies. Additionally, consider incorporating information on non-pharmacological interventions (e.g., allergen avoidance, exercise therapy) and culturally sensitive care.  

Sample Answer

     

Asthma Treatment Protocol

Pharmacological Treatment:

Step Preferred Medication Alternative Medication
Step 1 Short-acting beta-agonist (SABA) (e.g., albuterol) Short-acting beta-agonist (SABA) (e.g., levalbuterol)
Step 2 Low-dose inhaled corticosteroid (ICS) (e.g., fluticasone propionate) Low-dose inhaled corticosteroid (ICS) (e.g., budesonide)
Step 3 Combination ICS/long-acting beta-agonist (LABA) (e.g., fluticasone propionate/salmeterol) Combination ICS/LABA (e.g., budesonide/formoterol)
Step 4 High-dose ICS/LABA High-dose ICS/LABA with additional controller medication (e.g., leukotriene modifier, theophylline)
Step 5 Referral to specialist for further evaluation and management Referral to specialist for further evaluation and management

Reference: National Asthma Education and Prevention Program, Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2007.